297 related articles for article (PubMed ID: 14640044)
1. Report from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR) and the Domino Liver Transplant Registry (DLTR).
Ericzon BG; Larsson M; Herlenius G; Wilczek HE;
Amyloid; 2003 Aug; 10 Suppl 1():67-76. PubMed ID: 14640044
[TBL] [Abstract][Full Text] [Related]
2. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry.
Herlenius G; Wilczek HE; Larsson M; Ericzon BG;
Transplantation; 2004 Jan; 77(1):64-71. PubMed ID: 14724437
[TBL] [Abstract][Full Text] [Related]
3. Domino liver transplantation: risks and benefits.
Ericzon BG; Larsson M; Wilczek HE
Transplant Proc; 2008 May; 40(4):1130-1. PubMed ID: 18555132
[TBL] [Abstract][Full Text] [Related]
4. Transthyretin-derived amyloid deposition on the gastric mucosa in domino recipients of familial amyloid polyneuropathy liver.
Takei Y; Gono T; Yazaki M; Ikeda S; Ikegami T; Hashikura Y; Miyagawa S; Hoshii Y
Liver Transpl; 2007 Feb; 13(2):215-8. PubMed ID: 17029284
[TBL] [Abstract][Full Text] [Related]
5. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
[TBL] [Abstract][Full Text] [Related]
6. Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation.
Lladó L; Baliellas C; Casasnovas C; Ferrer I; Fabregat J; Ramos E; Castellote J; Torras J; Xiol X; Rafecas A
Liver Transpl; 2010 Dec; 16(12):1386-92. PubMed ID: 21117248
[TBL] [Abstract][Full Text] [Related]
7. New therapeutic approaches for familial amyloidotic polyneuropathy (FAP).
Ando Y
Amyloid; 2003 Aug; 10 Suppl 1():55-66. PubMed ID: 14640043
[TBL] [Abstract][Full Text] [Related]
8. Long-term consequences of domino liver transplantation using familial amyloidotic polyneuropathy grafts.
Yamamoto S; Wilczek HE; Iwata T; Larsson M; Gjertsen H; Söderdahl G; Solders G; Ericzon BG
Transpl Int; 2007 Nov; 20(11):926-33. PubMed ID: 17623052
[TBL] [Abstract][Full Text] [Related]
9. Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant.
Sattianayagam PT; Hahn AF; Whelan CJ; Gibbs SD; Pinney JH; Stangou AJ; Rowczenio D; Pflugfelder PW; Fox Z; Lachmann HJ; Wechalekar AD; Hawkins PN; Gillmore JD
Eur Heart J; 2012 May; 33(9):1120-7. PubMed ID: 21992998
[TBL] [Abstract][Full Text] [Related]
10. Transthyretin-related familial amyloidotic polyneuropathy.
Ando Y; Nakamura M; Araki S
Arch Neurol; 2005 Jul; 62(7):1057-62. PubMed ID: 16009758
[TBL] [Abstract][Full Text] [Related]
11. Combined heart and liver transplantation for familial amyloidotic neuropathy.
Pilato E; Dell'Amore A; Botta L; Arpesella G
Eur J Cardiothorac Surg; 2007 Jul; 32(1):180-2. PubMed ID: 17449267
[TBL] [Abstract][Full Text] [Related]
12. Continuous development of arrhythmia is observed in Swedish transplant patients with familial amyloidotic polyneuropathy (amyloidogenic transthyretin Val30Met variant).
Okamoto S; Hörnsten R; Obayashi K; Wijayatunga P; Suhr OB
Liver Transpl; 2011 Feb; 17(2):122-8. PubMed ID: 21280184
[TBL] [Abstract][Full Text] [Related]
13. Familial amyloidotic polyneuropathy and transthyretin.
Nagasaka T
Subcell Biochem; 2012; 65():565-607. PubMed ID: 23225017
[TBL] [Abstract][Full Text] [Related]
14. Domino liver transplantation.
Wilczek HE; Larsson M; Yamamoto S; Ericzon BG
J Hepatobiliary Pancreat Surg; 2008; 15(2):139-48. PubMed ID: 18392706
[TBL] [Abstract][Full Text] [Related]
15. [Gene therapy in familial amyloidotic polyneuropathy by single-stranded oligonucleotides (SSOs)].
Nakamura M; Ando Y
Rinsho Byori; 2004 Oct; 52(10):804-12. PubMed ID: 15624495
[TBL] [Abstract][Full Text] [Related]
16. Outcome of liver transplantation for familial amyloidotic polyneuropathy.
Sharma P; Perri RE; Sirven JE; Zeldenrust SR; Brandhagen DJ; Rosen CB; Douglas DD; Mulligan DC; Rakela J; Wiesner RH; Balan V
Liver Transpl; 2003 Dec; 9(12):1273-80. PubMed ID: 14625827
[TBL] [Abstract][Full Text] [Related]
17. Effect of recipient-derived cells on the progression of familial amyloidotic polyneuropathy after liver transplantation: a retrospective study.
Ohya Y; Jono H; Nakamura M; Hayashida S; Ueda M; Obayashi K; Misumi S; Asonuma K; Ando Y; Inomata Y
Ann Clin Biochem; 2010 Nov; 47(Pt 6):529-34. PubMed ID: 20930032
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation in transthyretin-related familial amyloid polyneuropathy.
Stangou AJ; Hawkins PN
Curr Opin Neurol; 2004 Oct; 17(5):615-20. PubMed ID: 15367866
[TBL] [Abstract][Full Text] [Related]
19. Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration.
Hou X; Aguilar MI; Small DH
FEBS J; 2007 Apr; 274(7):1637-50. PubMed ID: 17381508
[TBL] [Abstract][Full Text] [Related]
20. Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients' symptoms and complications.
Suhr OB
Amyloid; 2003 Aug; 10 Suppl 1():77-83. PubMed ID: 14640045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
